INTRODUCTION
Iron-sulfur (Fe/S) clusters are ubiquitous inorganic cofactors that are present in all forms of life 1 . Despite the chemical simplicity of Fe/S clusters, their biosynthesis and insertion into apoproteins within cells require dedicated and complex machinery 2, 3 . On the basis of the identification of proteins responsible for the biosynthesis of bacterial Fe/S enzymes, 2,4 a related ISC assembly machinery has been discovered in mitochondria of eukaryotes. In Baker's yeast, the best-studied eukaryote for this process, 15 proteins are known as members of the mitochondrial ISC assembly machinery (for recent reviews, see refs. 3, 5) . The key players are the cysteine desulfurase complex Nfs1/Isd11, which supplies sulfur to the scaffold protein Isu1 on which an Fe/S cluster is assembled de novo (see Fig. 1 ) (ref. 3) . This biosynthetic step requires the redox chain NADH-ferredoxin reductase (Arh1)-ferredoxin (Yah1) and the putative iron donor frataxin (Yfh1). The preassembled Fe/S cluster is then transferred to apoproteins involving a dedicated chaperone system 6 and the monothiol glutaredoxin Grx5. Some mitochondrial Fe/S proteins further depend on Isa1, Isa2 and Iba57 proteins 7 or GTP 8 for functional assembly.
In eukaryotes, Fe/S proteins are localized in the mitochondria, cytosol and nucleus 9 . Strikingly, maturation of the extra-mitochondrial Fe/S proteins depends on the function of the mitochondrial ISC assembly machinery 10 . A current working model ( Fig. 1) suggests that the mitochondria export a (still unknown) compound synthesized by virtue of the ISC assembly machinery to the cytosol where it is utilized by the so-called CIA machinery 11 . The export reaction is facilitated by members of the ISC export machinery, which encompass the mitochondrial inner membrane ABC transporter Atm1, the intermembrane space-located sulfhydryl oxidase Erv1 and glutathione. Over the past years, five CIA factors have been identified. Fe/S clusters are first assembled on the P-loop NTPases Cfd1 and Nbp35, which thus serve as scaffolds in the eukaryotic cytosol ( Fig. 1) (ref. 12) . Later steps require the iron-only hydrogenaselike protein Nar1 (ref. 13 ) and the b-propeller protein Cia1 (ref. 14) . Recently, the Fe/S protein Dre2 was found to be another crucial member of the CIA machinery but its function is still unclear 15 .
The ISC and CIA proteins found in yeast are highly conserved in eukaryotes, 16 suggesting that yeast provides a valuable model for Fe/S protein maturation in eukaryotes. In fact, seven mammalian relatives of yeast ISC and CIA proteins have been experimentally studied to date and shown to serve a similar function in the cell as their yeast counterparts [17] [18] [19] [20] [21] [22] [23] . The crucial importance of Fe/S proteins and their assembly machineries has been recognized by virtue of the association of lesions in ISC machinery genes with three human diseases (for a review, see refs. 3, 24) . First, a GAA triplet repeat expansion in an intronic region of frataxin is the most frequent cause of Friedreich ataxia, an autosomal recessive neurodegenerative disorder 25 . Second, a splicing defect in GLRX5 (encoding human Grx5) causes sideroblastic anemia 26 . Third, a myopathy of patients from northern Swedish descent has recently been shown to derive from a splicing defect in the ISCU gene (encoding human Isu1) 27, 28 .
The functional significance of the ISC and CIA machineries has gained progressive interest since a number of essential cytosolic and nuclear Fe/S proteins have been identified, the function of which may critically depend on their Fe/S cofactors [29] [30] [31] . In fact, the presence of essential Fe/S clusters in these proteins may explain the indispensable character of mitochondria and the ISC and CIA machineries for cell viability 29 . Ribosome maturation and protein translation require the 2Â [4Fe-4S] cluster-containing protein Rli1, which resides in both cytosol and nucleus 29, 32 . Other essential Fe/S proteins are involved in the integrity, maintenance and repair of DNA, but the presence of Fe/S clusters in these proteins in vivo has not been verified yet 30, 31 . Replication of the lagging strand critically depends on the primase complex, which includes the Fe/S cluster-containing large subunit Pri2 (ref. 30) . The DNA helicase Rad3 (XPD in humans) is one of the ten subunits of the RNA polymerase transcription factor IIH and is vital for nucleotide excision DNA repair 33 . A prokaryotic homolog of Rad3 has been shown by biochemical and structural studies to contain an essential [4Fe-4S] cluster inserted into its helicase fold 31, 34 . This protocol describes various experimental approaches to verify that these proteins in fact contain Fe/S clusters in the living cell.
Currently, the majority of novel Fe/S proteins are identified by isolation after heterologous expression in Escherichia coli, chemical reconstitution of Fe/S clusters, cysteine mutagenesis, bioinformatic analysis and/or X-ray crystallography 12, 13, 30, 31 . An important question is the relevance of the Fe/S cluster in the identified protein for the physiology of the original organism. For example, on synthesis in E. coli metal centers different from those present in the original host can be inserted, for instance due to the lack of dedicated metallochaperones. Well-known examples are the single iron-containing Clostridium pasteurianum rubredoxin 35 and the [2Fe-2S]-or [4Fe-4S]-containing Haemophilus influenzae IscU 36 , both of which bind zinc on heterologous expression in E. coli. Thus, sensitive in vivo assays in the original organism are required to complement biochemical and structural approaches used to identify novel Fe/S-containing proteins. Here, we provide several methods intended to verify the presence of Fe/S clusters in proteins of interest in vivo 35, 36 . We describe the use of radiolabeled iron ( 55 Fe) and several enzymatic assays to determine the presence of Fe/S clusters in mitochondrial, cytosolic and nuclear proteins. We further outline how the assays described here serve to unequivocally identify new biogenesis components, i.e., members of the ISC and CIA machineries. The use of genetic depletion methods to diminish the cellular amounts of these usually essential proteins allows the investigation of their role in vivo. For instance, the stages at which these factors perform their function in the biosynthetic pathway can be determined 12, 37 . In turn, this experimental approach opens the way to address the phenotypes associated with the depletion of the ISC and CIA components. A number of additional assay systems for testing the biogenesis of Fe/S proteins in whole cells will not be described here because of their indirect character. The reader is referred to the summary of these approaches in refs. 3,38,39. For the study of maturation of the ferredoxin Yah1 (ref. 40 ) and aconitase 8 , specialized protocols have been developed for the use with isolated mitochondria. Aconitase can be measured qualitatively in a gel-based assay (zymogram) 21 . A non-radioactive method, which also uses regulatable promoters, has recently been developed for a bacterial system, Azotobacter vinelandii 41, 42 . This method allows determination of both Fe/S cluster amount and type, but might not be applicable for eukaryotic systems due to inherently lower protein amounts.
Experimental design
Measurement of enzymatic activities of Fe/S proteins. There are several assays available to measure Fe/S enzyme activities at their natural abundance (Table 1) for testing the cellular Fe/S protein biogenesis machinery. As the activity of these enzymes depends on the presence of a particular cluster type, i.e., [4Fe-4S] in aconitase 43 , activity measurements provide information on both the quantity and the Fe/S cluster integrity. It should be noted, however, that this strategy does not necessarily provide information about the maturation efficiency of Fe/S proteins inside the cell, i.e., about de novo Fe/S protein biogenesis activity, as cluster lability, iron status 43 and oxidative stress 44 can lead to the damage or removal of the Fe/S cluster from the protein of interest.
Methods for the determination of two cytosolic Fe/S enzymes (isopropylmalate isomerase and sulfite reductase) and two mitochondrial Fe/S enzymes (succinate dehydrogenase and aconitase) are given in Boxes 1 and 2, respectively. The activity of isopropylmalate isomerase can be detected by the formation of the UVabsorbing double bond of isopropylmaleate on dehydration of 3-isopropylmalate 10 . In a similar manner, formation of cis-aconitate from isocitrate in concentrated aconitase preparations (mitochondria) can be followed 10 . For diluted aconitase samples (whole-cell extract), this assay cannot be used due to the high UV absorbance from DNA and other proteins. Instead, formation of NADPH at 340 nm can be recorded 7 After import of reduced iron (red circle) into mitochondria by the carrier proteins, Mrs3/4 (mitoferrin), the iron-binding protein frataxin is believed to deliver Fe to the scaffold protein Isu1 (yeast contains a second highly related protein termed Isu2). Sulfur (yellow circle) is released from cysteine by the cysteine desulfurase complex Nfs1-Isd11 generating alanine. The sulfur is transferred to Isu1 and possibly reduced by the electron transfer chain NADH-ferredoxin reductase Arh1-ferredoxin Yah1. These reactions lead to the de novo assembly of an Fe/S cluster on Isu1. The cluster is then transferred to apoproteins (Apo), a reaction facilitated by the glutaredoxin Grx5 and the chaperone system Ssq1-Jac1-Mge1. Functional activation of aconitase-and biotin synthase-like Fe/S proteins requires the additional function of Isa1-Isa2-Iba57. Extra-mitochondrial Fe/S proteins depend on most of the mitochondrial ISC assembly components for maturation as well as on the ISC export machinery with the central component Atm1, which exports an unknown (?) compound to the cytosol for use by the CIA machinery. This leads to assembly of Fe/S clusters on the P-loop NTPases Cfd1-Nbp35. The Fe/S cluster is then transferred to cytosolic and nuclear apoproteins involving the function of Nar1 and Cia1. The functional step of the essential CIA protein Dre2 has not been identified yet. GSH, glutathione. For further details, see text and ref. 3 . isocitrate formation from cis-aconitate is coupled with isocitrate dehydrogenase and NADP + . Succinate dehydrogenase activity in intact mitochondria harboring intrinsic quinones and the bc 1 complex is detected by cytochrome c reduction 7 . If the bc 1 complex is lacking or the mitochondria are damaged, reduction of the artificial electron acceptor DCPIP can be used instead. The assay for sulfite reductase employs detection of the acid-labile sulfide formed from NADPH-dependent SO 3 2À reduction. NADPH is (re)generated in situ from NADP + with glucose-6-phosphate dehydrogenase and glucose-6-phosphate 14 . In a noncontinuous assay, the enzymatically formed sulfide condenses in acidic environment in an Fe 3+ -dependent manner with two N,N-dimethyl-pphenylene diamine molecules to the conveniently detectable methylene blue 45 .
Ideally, Fe/S proteins used as biosynthesis markers should be abundant enzymes that are expressed in a largely constitutive manner and the activity of which is not influenced by growth conditions. However, as the majority of the Fe/S proteins are metabolic enzymes or may be subject to regulation similar to any non-Fe/S protein involved in biosynthetic processes, inherent alterations of the protein levels may occur that have to be accounted or corrected for. For instance, decreased levels of sulfur (methionine/cysteine) influence sulfite reductase expression in yeast 46 . Furthermore, the type of carbon source utilized determines the extent of fermentation and thereby influences the activities of fermentative cytosolic and mitochondrial enzymes, including those of the respiratory chain and aconitase 47 . The yeast strain used should also be considered. High activity of isopropylmalate isomerase (Leu1) is particularly observed in the yeast W303 genetic background 10 . Effects by strain and medium differences are not confined to the yeast system. In human cell lines, complications may arise from significant metabolic responses. Finally, cell density affects the cellular iron status, which in turn can complicate Fe/S protein activity measurements, in particular those of cytosolic aconitase/IRP1 (ref. 23) .
Caution should be taken with the use of enzymes that require multiple cofactors ( Table 1) . The presence of flavin and molybdenum cofactor (MoCo) is a serious drawback for the use of xanthine dehydrogenase (human and plant cells) and that of flavin and siroheme for sulfite reductase (yeast) as Fe/S protein marker enzymes. Biosynthesis of MoCo requires other Fe/S proteins and the lack of insertion of other cofactors could hinder Fe/S cluster assembly 48 . Certain enzymes, which in some organisms serve as convenient indicators for Fe/S protein maturation, are absent in others, and vice versa. For example, Baker's yeast lacks a respiratory complex I and xanthine dehydrogenase but contains isopropylmalate isomerase and dihydroxyacid dehydratase (Ilv3), whereas human cells have the opposite configuration 3 . An even more complex situation is found for DNA glycosylases, adenosine-5¢-phosphosulfate reductase, ferrochelatase and the AC40 subunit of RNA polymerase II, 49 which are present in plants, fungi and humans but, depending on the organism, possess or lack Fe/S clusters.
The sensitivity of Fe/S enzyme detection can usually be increased by cell fractionation and isolation of the respective compartments harboring the Fe/S enzyme of interest. This procedure substantially diminishes background values and in many cases is crucial for detection of low levels of activity (e.g., for cytosolic aconitase in human cells 19 ). If necessary, marker enzymes can be artificially introduced into an organism or cellular compartment by ectopic expression. This methodology allows convenient determination of soluble enzyme activities. Examples include cytosolic human aconitase (IRP1) in a yeast deletion mutant lacking mitochondrial aconitase 50 , cytosolic 15 or mitochondria-targeted 51 isopropylmalate isomerase (Leu1) in a yeast cell lacking or with low cytosolic Leu1. In addition to the introduction of suitable marker Fe/S proteins, such experiments show that central parts of both the ISC and CIA machineries do not exhibit pronounced target specificity for Fe/S proteins of one given compartment. 50, 51 Incorporation of radioactive iron into Fe/S proteins in vivo. The pulse radiolabeling of yeast cells with 55 Fe provides a faithful assay for the estimation of the de novo biogenesis of Fe/S cluster-containing proteins in vivo 10 . A similar approach has been employed to study Fe/S protein assembly in isolated or lysed mitochondria in vitro 52 . Even though the high-energy isotope 59 TNETG buffer: 10 mM Tris/Cl pH 7.4, 2.5 mM EDTA, 150 mM NaCl, 10% (vol/vol) glycerol, 0.5% (vol/vol) Triton X-100: per 500 ml use 5 ml of 1 M Tris-HCl pH 7.4, 2.5 ml of 0.5 M disodium EDTA (pH 7.4), 37.5 ml of 2 M NaCl, 50 ml of glycerol and 25 ml of 10% (wt/vol) Triton X-100 200 mM PMSF in 100% ethanol. m CRITICAL STEP Prepare just before use; PMSF rapidly hydrolyses. ! CAUTION PMSF is toxic; wear suitable protective clothing, gloves and eye/face protection. 0.1 M NADP + in ddH 2 O 20 mM cis-aconitic acid in ddH 2 O Triethanolamine buffer: 100 mM triethanolamine adjusted to pH 8 with 1 M NaOH IDH 40 U ml À1 in triethanolamine buffer with 10% (wt/vol) glycerol, store in small aliquots at À80 1C Isopropylmalate isomerase (Leu1) buffer: 20 mM Tris-Cl pH 7.4, 50 mM NaCl 10 mM DL-threo-3-isopropylmalic acid in ddH 2 O, dilute freshly from a 100 mM stock solution in ddH 2 O stored frozen at À20 1C Phosphate buffer: mix 1 M K 2 HPO 4 and 1 M KH 2 PO 4 in the right proportion to obtain pH 7.5 100 mM glucose-6-phosphate dipotassium salt in 20 mM phosphate buffer (pH 7.5) 100 U ml À1 glucose-6-phosphate dehydrogenase, dissolve 500 U in 5 ml of 0.1 M phosphate buffer (pH 7.5), store in small aliquots at À80 1C overproduction by substitution of the chromosomal promoter or expression from high copy plasmids utilizing suitable strong promoters (TDH3, GAL1-10 or MET25) 56 . The high natural concentration of iron in growth media and inside cells requires the depletion of ambient iron by cell cultivation at submicromolar iron concentrations ('iron poor' conditions) before addition of the radioisotope 10 . This requirement does not pose a limitation in experiments with yeast cells, as their growth is only mildly affected at low iron concentrations and the frequent use of plasmids urges the use of defined (minimal) media. For radiolabeling of human cell lines, however, the depletion of iron severely decreases cell growth 23 , and an efficient radiolabeling procedure has not yet been described.
Our standard radiolabeling procedure is described in this protocol. Radiolabeling of iron-starved yeast cells with 55 Fe is performed for 1-4 h in the presence of the reducing agent ascorbate. The presence of ascorbate prevents the formation of ferric precipitates in the growth medium. Following radiolabeling, cells are lysed with glass beads, a soluble cell extract is prepared and the 55 Fe/S proteins are immunoprecipitated with specific antibodies (see Fig. 2 ). Alternatively, N-or C-terminal epitope tags can be used to affinity purify the Fe/S proteins of interest. In our hands, the tandem affinity purification (TAP), triple hemagglutinin (3HA) or Myc tags work well, provided the proteins are not functionally compromised. The amount of radioactive iron associated with the Fe/S protein of interest is quantified by liquid scintillation counting. The specificity of the 55 Fe association as part of an Fe/S cluster may be verified by testing the dependence on members of the ISC and CIA machineries (see below). On depletion of particular ISC and CIA components by growth on glucose of yeast strains harbouring a GAL promotor in front of the respective genes, the 55 Fe incorporation into Fe/S proteins usually drops at least fivefold 10, 13, 14, 29, 51, 55 . As a control, the cellular uptake of 55 Fe during the labeling period is measured, which reflects the extent of contamination with nonradioactive Fe in the medium. Vital 55 Fe uptake is also a viability and fitness parameter for the cells as active transport of Fe against a concentration gradient can only be carried out, if the cellular energy status is not compromised. In higher eukaryotes, ferrochelatase is a mitochondrial Fe/S protein 3 , and the formation of radioactive heme, therefore, can be used to indirectly (20-24 1C) remove the supernatant and resuspend the cell pellet with 10 ml of ddH 2 O, transfer to a 15-ml Falcon tube and repeat the centrifugation. m CRITICAL STEP All subsequent steps should be carried out at 4 1C. 3. Resuspend the pellet in 500 ml of ice-cold TNETG buffer; add 10 ml of 0.2 M PMSF and 1 ml of glass beads (with a porcelain spoon). Close the lid tightly. Vortex at maximum speed with the lid side of the tubes contacting the rotating plate for 1 min, repeat the vortexing three times with intermittent 1 min cooling periods on ice. m CRITICAL STEP Ensure that there are no glass beads trapped in the lid. 4. Centrifuge for 5 min at 2,000g at 4 1C. Transfer the supernatant to 1.5-ml microfuge tubes and centrifuge for 10 min at 13,000g. Transfer the supernatant to a new microfuge tube. Save 50 ml for protein determination 73 . 5. The supernatant (typically 3-6 mg ml À1 ) can be used to measure Fe/S enzyme activity using the assays of options A-C. These enzyme measurements can be performed under aerobic conditions but should be carried out immediately after isolation of the cell extracts to prevent deterioration of the enzymes.
(A) Aconitase (coupled assay) TIMING B1 h (including cell extract preparation) (i) Pipette 950 ml of triethanolamine buffer, 12 ml of 20 mM cis-aconitic acid, 10 ml of 40 U ml À1 IDH, 12 ml of 0.1 M NADP + and cell extract (50 mg protein) into the sample cuvette. Omit cis-aconitic acid and IDH in the reference cuvette. Mix well.
(ii) Measure the increase of absorbance at 340 nm for 2-4 min; a short lag phase is usually observed. De 340 nm ¼ 6,200 M À1 cm À1 .
(B) Sulfite reductase TIMING B1.5 h (including cell extract preparation) (i) During the cell extract preparation step, prepare a master mix for 10 reactions: 500 ml of 1 M phosphate buffer, pH 7.5, 10 ml of 0.1 M NADP + , 500 ml of 0.1 M glucose-6-phosphate solution, 25 ml of glucose-6-phosphate dehydrogenase (0.1 U ml À1 ) and 2.965 ml of ddH 2 O.
(ii) Aliquot 400 ml of the master mix into 1.5-ml microfuge tubes, rapidly add sample (50 ml buffer for the reagent blank, 10-50 ml Li 2 S calibration standard solution adjusted to 50 ml with buffer or 50 ml of cell extract (B200 mg of protein)), mix and incubate for 10 min at 30 1C. ! CAUTION Li 2 S is toxic; wear suitable protective clothing, gloves and eye/face protection. (iii) Add 50 ml of 10 mM Na 2 SO 3 and then immediately add 100 ml of DMPD solution, 100 ml of ferric reagent and mix. This sample serves as t¼0 min control. ! CAUTION DMPD is neurotoxic; wear suitable protective clothing, gloves and eye/face protection. sample Fe/S cluster biogenesis (Fig. 2) . Owing to its high solubility in organic solvents, heme can be quantitatively extracted from the cell lysates into the organic phase after acidification 57 . The degree of 55 Fe incorporation into heme is quantified by liquid scintillation counting. In a limited number of cases, the inherent lability of protein-bound Fe/S clusters may require specialized experimental conditions such as anaerobic immuno-or affinity purification of the Fe/S protein, shorter and/or less stringent washing conditions 3. The enzymatic activity of the mitochondrial Fe/S protein can be measured using the assays described in options A-C. than those used for stable Fe/S proteins and optimized times for radiolabeling. As 55 Fe incorporation does not give any information on the cluster type, ideally radiolabeling assays and methods that detect the cluster type (i.e., enzymatic activity measurement) are performed in parallel [12] [13] [14] 55 .
The purchase, storage, use and disposal of the 55 Fe isotope require an appropriate license, training of staff, planning or construction of facilities (isotope lab) and monitoring of safety and contamination.
Depletion of ISC or CIA components. The specificity of the assays described above can best be verified by analyzing the dependence of the Fe/S enzyme activities or 55 Fe/S cluster incorporation on the function of known components of the ISC and CIA machineries 10, 29 . Mitochondrial target Fe/S proteins specifically depend on the mitochondrial ISC assembly machinery for maturation, whereas cytosolic and nuclear Fe/S proteins require the activities of the two ISC systems and the CIA machinery 3 (Fig. 1) . Potential novel members of the three machineries identified by other methods (genetic screens and bioinformatics) can be investigated. Deletion of the majority of the ISC and CIA genes is lethal necessitating genetic means to downregulate synthesis of the encoded proteins by regulated gene expression. A convenient promoter is that of the GAL1-10 gene, which is induced in the presence of galactose and repressed by glucose. To create a Gal-YFG1 (your favorite gene 1) strain, the endogenous YFG1 promoter is exchanged for that of GAL1-10 by generating a suitable PCR product that can be inserted in front of the YFG1 promoter locus by homologous recombination 58 . Attenuated versions of this promoter termed GALL have been developed avoiding overexpression with galactose and allowing faster depletion in the presence of glucose. It is crucial to test for possible sugar effects that may arise, e.g., from the switch from respiratory to fermentative growth. As general glucose repression is particularly weak in the W303 yeast genetic background, this strain is well suited for the use of the GAL1-10 promoter during (mitochondrial) Fe/S protein biogenesis investigations. Other suitable depletion techniques are the tetracycline-regulated promoter system 59 , the heat-induced proteolysis with the degron system 60 , temperature-sensitive strains 61 and the decreased abundance by mRNA perturbation approach 62 . Downregulation of the target genes must be optimized individually to assure the occurrence of phenotypical consequences, yet no viability loss. The specificity of downregulation should be verified by complementation with a plasmid-borne YFG1 gene. For the Gal-YFG1 strains, depletion to physiologically critical levels is achieved by several passages in liquid media under repressive conditions (see Fig. 2b in ref. 29) . Once the behavior of the Gal-YFG1 strain has been determined, the yeast cells can be used for the assays described above. If necessary, the yeast strain can be transformed with a plasmid encoding a potential Fe/S protein using a non-sugar-dependent promoter.
Depletion of the ISC and CIA proteins in human cells such as HeLa cell lines is achieved by the RNA interference technology (see e.g., ref. 19 ). Depletion of the proteins under study is followed by western blotting. To avoid off-target effects of the RNA interference treatment, it is recommended to validate the specificity of the physiological depletion effects by complementing the cells by synthesis of the native protein using genes with silent mutations that are resistant to RNA interference. In many cases, one round of RNA interference treatment is not sufficient to reach critical levels of depletion. Therefore, it is useful to repeat the treatment until a reasonable depletion is achieved without losing cell viability 17 HEPES buffer (20 mM HEPES/KOH pH 7.4) Per 100 ml, use 4 ml 0.5 M HEPES adjusted to pH 7.4 with 2 M KOH, and autoclave. TNETG buffer (10 mM Tris/Cl pH 7.4, 2.5 mM EDTA, 150 mM NaCl, 10% (vol/vol) glycerol, 0.5% (vol/vol) Triton X-100) Per 500 ml, use 5 ml of 1 M Tris-HCl pH 7.4, 2.5 ml of 0.5 M disodium EDTA (pH 7.4), 37.5 ml of 2 M NaCl, 50 ml of glycerol, and autoclave. On the day of use, add Triton X-100 to a final concentration of 0.5% (vol/vol).
Beads for immunoprecipitation All steps should be carried out at 4 1C.
Beads for immunoprecipitation of TAP-tagged proteins: Suspend the commercial IgG Sepharose 6 Fast Flow beads by inversion, transfer 500 ml to a 1.5-ml microfuge tube and centrifuge for 5 min at 800g at 4 1C to remove the supernatant. Wash three times with 500 ml of TNETG buffer and finally adjust the volume to 500 ml with TNETG buffer. Beads for immunoprecipitation with serum raised against a protein of interest: Swell 50 mg of Protein A-Sepharose CL-4B in 0.5 ml cold TNETG buffer in a 1.5-ml microfuge tube by incubation for at least 30 min in a rotary shaker. Centrifuge for 5 min at 800g at 4 1C, remove the supernatant and add 500 ml of antibody serum. After incubation for at least 1 h in a rotary shaker, centrifuge for 5 min at 800g at 4 1C and remove the supernatant. Wash five times with 500 ml of TNETG and centrifuge as before. Adjust the volume to 500 ml with TNETG buffer.
Beads for immunoprecipitation with antibodies against hemagglutinin or Myc epitopes coupled to agarose: The 25% (wt/vol) commercial suspension can directly be used after repeated inversion. m CRITICAL Resuspend the beads by gentle swirling or inverting. Do not vortex, use a magnetic stirrer or spatula. Use blue or yellow pipette tips where 4 mm of the end have been cutoff with scissors, otherwise beads fracture and distribute unevenly. Step 1 onto a quadrant of an SC agar plate with 2% (wt/vol) galactose and appropriate auxotrophy selection markers 64 . Incubate at 30 1C until a rather continuous but not overgrown lawn has developed, which usually takes 2-3 d. m CRITICAL STEP For stronger protein depletion, some galactose-regulatable mutants have to be downregulated by additional growth on glucose-containing SC agar plates before growth in liquid medium. Cell densities should always remain lower than an OD of 2.
Confirm the presence of the protein of choice in the transformants (optional) TIMING B8 h including SDS-PAGE and western blot 3| Take a few milligrams of cells from each quadrant (Step 2) using a yellow tip, transfer the cells to a 1.7-ml microfuge tube filled with 1 ml of ddH 2 O, centrifuge for 3 min at 13,000g, 4 1C. Add 75 ml of alkaline lysis mix and incubate for 10 min on ice. Add 575 ml of 50% (wt/vol) TCA, vortex and incubate for 10 min on ice and centrifuge for 3 min at 13,000g, 4 1C. Remove the supernatant and wash the pellet twice with 1 ml of ice-cold acetone, dissolve in 50 ml sample buffer 63 and perform western blot after SDS-PAGE 63 . ! CAUTION TCA is corrosive, causes severe burns, wear suitable protective clothing, gloves and eye/face protection.
Pre-culture of yeast cells TIMING 15 min
4| Inoculate 50 ml of SC medium supplemented with a final concentration of 2% (wt/vol) galactose (or 2% (wt/vol) glucose) and the appropriate auxotrophy selection markers 64 with a small scoop of yeast cells from the plate (Step 2). Incubate at 30 1C for 24 h. m CRITICAL STEP Some galactose-regulatable mutants have to be downregulated by repeating this pre-culturing step in SC glucose medium. Cell densities should always remain lower than an OD of 2 (see Step 5) . ? TROUBLESHOOTING Culture of yeast cells in iron-free medium TIMING B1 h 5| Determine the OD of the pre-culture from Step 4 at 600 nm.
6|
Remove an appropriate volume of the pre-culture from Step 4 for the inoculation of 100 ml of iron-free SC medium at an OD of 0.2 (i.e., 20 divided by the OD measured in Step 5 (in milliliters)).
7|
Transfer the culture to 50-ml Falcon tubes and centrifuge for 5 min at 2,000g at room temperature. Remove the supernatant and add 10 ml of sterile ddH 2 O, vortex the cell pellet and repeat the centrifugation as before.
8| Prepare sterile 300 ml Erlenmeyer flasks with 100 ml of iron-free SC medium with 2% (wt/vol) galactose (or 2% (wt/vol) glucose) and the appropriate auxotrophy selection markers 64 . Use 10 ml of this medium to resuspend the pellets obtained in
Step 7 and transfer the cells to the same flask. Grow the cells overnight (16 h) in a shaking incubator at 150 r.p.m., 30 1C.
Radiolabeling with 55 FeCl 3 TIMING B3 h 9| Harvest the cells from the 100 ml cultures into a single 50-ml Falcon tube by two successive centrifugations for 5 min at 2,000g at room temperature.
10| Add 10 ml of ddH 2 O and resuspend the cell pellet, transfer to a 15-ml Falcon tube and centrifuge for 5 min at 1,500g at room temperature.
11| Determine the wet weight of the cell pellet (0.5-0.75 g). Resuspend the cells in 10 ml of iron-free SC medium with 2% (wt/vol) galactose (or 2% (wt/vol) glucose). ? TROUBLESHOOTING 12| Remove the appropriate volume that corresponds to 0.5 g of cells and place in a 15-ml Falcon tube. Adjust the volume to 10 ml with iron-free SC medium with 2% (wt/vol) galactose (or 2% (wt/vol) glucose). Cell extract preparation TIMING B1 h 15| Transfer the 55 Fe-labeled cells to a 15-ml Falcon tube and harvest by centrifugation for 5 min at 2,000g at room temperature. Remove the supernatant and wash the cell pellet with 10 ml of citrate buffer to remove residual 55 Fe from the medium and the outside of cells. Centrifuge for 5 min at 2,000g at room temperature, remove the supernatant and wash the cell pellet with 2 ml of 20 mM HEPES-KOH, pH 7.4 to remove the citrate buffer.
16| Centrifuge the cells for 5 min at 2,000g at room temperature, remove the supernatant by pipetting and determine the wet weight of the cells (typically 0.45-0.55 g).
17|
Resuspend the cell pellet in a volume of TNETG buffer equal to the mass of the cell pellet and place the tubes on ice. Add 10 ml of 0.2 M PMSF and 1 ml of glass beads. Close the lid tightly. 19| Centrifuge the cells for 5 min at 2,000g at 4 1C to pellet the glass beads and unlysed cells. Transfer the supernatant to 1.5-ml microfuge tubes, centrifuge for 10 min at 13,000g at 4 1C and carefully transfer 450-500 ml of the supernatant to a fresh tube. m CRITICAL STEP Avoid the transfer of the lipid-containing surface layer.
20| Remove 5 ml of the extract for the determination of the cellular iron uptake: mix with 45 ml of ddH 2 O in a 1.5-ml microfuge tube, add 1 ml of scintillation fluid, vortex for 30 s and determine the radioactivity by scintillation counting. For western blotting of Fe/S and non-Fe/S marker proteins, take a 25-ml sample of the extract and add 175 ml of ice-cold 30% (wt/vol) TCA, vortex and incubate on ice for 10 min. ! CAUTION TCA is corrosive, causes severe burns, wear suitable protective clothing, gloves and eye/face protection 21| Centrifuge the TCA-treated extract from Step 20 for 10 min at 13,000g, 4 1C and remove the supernatant. Add 500 ml of ice-cold acetone, repeat the centrifugation step and wash again with 500 ml of ice-cold acetone. Remove the supernatant and air dry the protein pellet. Dissolve the pellet in 50 ml of sample buffer. 63 ' PAUSE POINT The sample can be stored up to 1 month at -20 1C before SDS-PAGE and western blotting (see Step 25) .
Immunoprecipitation TIMING B1.5-2 h 22| Add either 20-50 ml of self-made antibody Protein A-Sepharose beads, 20-40 ml of commercially available IgG Sepharose beads, or 10-15 ml of anti-hemagglutinin or anti-Myc (A-14) beads to 200-250 ml of cleared cell extract (from Step 19) and incubate the mixtures in 1.5-ml microfuge tubes for 1 h on a rotary shaker at 4 1C.
23|
Collect the beads by centrifuging for 5 min at 800g at 4 1C and carefully remove the supernatant by repeated pipetting with a 200 ml pipette. Wash the beads three times in 500 ml of ice-cold TNETG and collect the beads by centrifugation. m CRITICAL STEP The first two removals of supernatant are critical for a successful experiment (i.e., low background). Use a black background to improve visibility of the beads during pipetting.
24| Add 50 ml of ddH 2 O and 1 ml of scintillation cocktail to the beads, vortex for 30 s, place the microfuge tube in a plastic counting vial and measure the 55 Fe radioactivity associated with the beads in a scintillation counter with settings appropriate for 3 H (ref. 67) . Step 3, confirm the presence of protein of choice in transformants (optional): B8 h including SDS-PAGE and western blot Step 4, CIA proteins in the pathway of cytosolic Fe/S cluster assembly 12 . Typical results for 55 Fe incorporation into reporter Fe/S proteins in wild-type cells are given in Table 3 . Except for Aco1 and Leu1, the Fe/S proteins were overproduced from expression plasmids. Likewise, Table 3 provides representative specific enzyme activities in galactose-grown wild-type cells. Appropriate non-Fe/S enzymes should be measured in parallel as controls 10, 19, 68 . Figure 3 shows typical results for an in vivo 55 Fe incorporation experiment in yeast. In Figure 3a , the mitochondrial cysteine desulfurase Nfs1 was synthesized or depleted in Gal-NFS1 cells by growth in galactose-or glucose-containing media, respectively. These cells carry the NFS1 gene under the control of the GAL1-10 promoter, which is induced by galactose and repressed by glucose. The incorporation of 55 Fe into the scaffold Cfd1 (carrying a TAP tag) and the cytosolic Fe/S target protein Leu1 was determined as described above. Incorporation of 55 Fe into both Cfd1 and Leu1 strongly decreased on depletion of Nfs1 verifying that the associated 55 Fe is part of an Fe/S cluster. Detection of 55 Fe on Cfd1 depended on its overproduction, whereas wild-type levels of Leu1 were sufficient for the measurement of 55 Fe/S cluster assembly. The background levels of 55 Fe assay can be determined, e.g., by omitting production of Cfd1 (Fig. 3a) or by the use of pre-immune serum instead of specific antiserum. Typically, the background values vary between 2 and 15% of the total signal depending on the Fe/S protein and antiserum. In Figure 3b , we used the yeast mutant Gal-CFD1 with the CFD1 gene under the control of the GAL1-10 promoter to deplete Cfd1 (see western blot in Fig. 3b ). After 55 Fe radiolabeling, cell extracts were prepared as described under Protocols. Cytosolic (Leu1) and mitochondrial (Bio2) Fe/S proteins were immunoprecipitated with specific antibodies coupled to Protein A-Sepharose beads, whereas the HA-tagged Fe/S proteins Rli1 (cytosol/nucleus) and Ntg2 (nucleus) were immunoprecipitated using commercially available HA beads. The latter three Fe/S proteins require overproduction from appropriate plasmids due to their low cellular abundance. The radioactivity associated with mitochondrial Bio2 remained almost unchanged on depletion of cytosolic Cfd1 (Fig. 3b) . In contrast, the nuclear and cytosolic Fe/S proteins had only 15-25% of the radioactivity associated compared with galactose-grown cells. These data, in conjunction with western blotting experiments assessing the presence or absence of the relevant proteins, show the specific function of Cfd1 for Fe/S cluster assembly on extra-mitochondrial proteins. 55 Fe according to the Protocol and cell extracts were prepared. An aliquot of the extract was immediately TCA-precipitated for detection of the proteins by western blotting (lower panels). The remainder (B250 ml) was added to IgG (Cfd1-TAP), anti-HA antibodies (Rli1-HA and Ntg2-HA) or home-made antibodies (against yeast Leu1 and Bio2) coupled to beads. After 1 h of incubation, the beads were extensively washed, and the amount of 55 Fe associated with the beads was determined by scintillation counting (upper panels 
